160 likes | 394 Views
. TNT: Treating to New Targets. . LaRosa JC et al. N Engl J Med. 2005;352.. Hypothesis:Lowering LDL-C levels to well below 100 mg/dL could yield an incremental clinical benefitParticipants:10,001 patients with stable CHD and LDL-C 130-250 mg/dLTreatments:Atorvastatin 10 mg and 80 mgMedian
E N D
3. TNT: Treating to New Targets
5. TNT: Design
6. TNT: Baseline characteristics
7. TNT: CV history of participants
8. TNT: Baseline lipids
9. TNT: Treatment effects on LDL-C
10. TNT: Treatment effects on primary outcome
11. TNT: Treatment effects on first major coronary event CHD death, MI, resuscitation after cardiac arrest
12. TNT: Treatment effects on CHD death, MI
13. TNT: Treatment effects on stroke
14. TNT: Non-CV mortality
15. TNT: Tolerability of treatments
16. TNT: Extending and confirming benefit of LDL-C lowering beyond current guidelines